Delivery Order SPE2DB24D3013-SPE2DB25FFRBE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections, with a firm fixed price ceiling value of $1,088.36. This non-competitive, competitively awarded delivery order is set to be completed by September 19, 2025, and will be fulfilled from the company's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen auto-injectors, with a ceiling value of $1,904.63 and a firm fixed price structure. This non-set-aside, competitively awarded delivery order is scheduled for completion by August 7, 2025, with performance executed from the company's headquarters in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $1,904.63 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injections on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier to the federal government. The contract was executed without set-aside designation, indicating open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injections with a ceiling value of $1,088.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 11, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's capability to compete in open...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.81 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injections. This competitive, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of September 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens with a ceiling value of $26,411.84. This firm fixed price delivery order represents a non-competitive award and is scheduled for completion by September 29, 2025. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,613.98 on September 5, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and a completion date of September 8, 2025. The product will be performed and sourced from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,081.35 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order requires performance at the contractor's Conshohocken, Pennsylvania location. The award represents a single delivery transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens valued at $5,564.41. This delivery order, issued under a firm fixed-price contract with no set-aside designation, is due for completion by July 14, 2025. AmerisourceBergen will fulfill this order from its corporate office in Conshohocken, Pennsylvania, where the company maintains operations as a primary pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injections, with a contract ceiling value of $2,720.90 and a completion date of June 26, 2025. This competitive, non-set-aside delivery order utilizes firm fixed pricing and represents a single pharmaceutical supply transaction under AmerisourceBergen's existing federal contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, which is also the company's...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFRBEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injections valued at $6,422.82, with completion expected by September 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a prime vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems globally. The company's broad contract portfolio demonstrates its capacity to fulfill diverse federal medical procurement requirements across multiple therapeutic domains, positioning it as a key vendor for DoD healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 9/26/25 |